| 标题 |
Comparative risk of fibrosis progression with sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitors in metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus with low-to-intermediate fibrosis |
| 网址 | |
| DOI |
10.3350/cmh.2025.0825
doi
|
| 其它 |
期刊:Clinical and Molecular Hepatology 作者:Jonggi Choi; Daniel Fulop; Vy H. Nguyen; E. Przybyszewski; Jiunn Song; et al 出版日期:2025-11-11 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)